American International Group, Inc. Bellerophon Therapeutics, Inc. Transaction History

American International Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$3.83 - $5.65 $10,011 - $14,769	-2,614 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$5.07 - $8.27 $30 - $49	6 Added 0.23%	2,614 $14,000
Q4 2020 Feb 12, 2021	SELL	$6.12 - $10.37 $452 - $767	-74 Reduced 2.76%	2,608 $17,000
Q3 2020 Nov 04, 2020	BUY	$9.27 - $13.79 $5,348 - $7,956	577 Added 27.41%	2,682 $27,000
Q2 2020 Aug 12, 2020	BUY	$9.43 - $20.28 $19,850 - $42,689	2,105 New	2,105 $26,000

44K

Ticker BLPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,545,450
Market Cap $382K
Description
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.